CLEVELAND, July 9, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies and delivering related services for the clinical trials industry, today announced an expedited trial deployment program.
"We know deadlines are important," said Laurence P. Birch, Chairman and CEO, DATATRAK. "Selecting the right software to meet those deadlines is crucial. That's why we worked with our customers to design our expedited trial program."
There are two levels in the DATATRAK Expedited Trial Deployment program:
- Essential Program: Four week deployment with minimal customization
- Robust Program: Six week deployment with moderate customization
The program also includes two add on features:
- Optional addition of UX RTSM™, Randomization and Trial Supply Management
- Optional custom import and custom export
"Getting started faster is just the beginning. What good is expedited trial deployment if you lose time during the trial? DATATRAK ONE® UX EDC and Medical Coding™ delivers real time savings throughout the research. Data entry is simplified. Reporting is at your fingertips."
"We work tirelessly to simplify clinical research. Our cloud-based unified clinical platform does just that," concluded Birch.
DATATRAK is a global leader offering transformational software and consulting services to the clinical trials industry. The company simplifies clinical research with the unified dClinical™ platform, safely accelerating clinical trials, from Concept to Cure®.
Join DATATRAK Thought Leaders:
Tweet: Save valuable time from deployment to completion with our expedited trial deployment program http://ow.ly/PlYZX
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Chicago, Illinois; Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina; and Plymouth, Minnesota. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full-year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.